您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览22

Collagen type 4 alpha 1 (COL4A1) and collagen type 13 alpha 1 (COL13A1) produced by urothelial cancer cells support the vital oncogenic property of tumor invasion. We investigated the diagnostic and prognostic capability of COL4A1 and COL13A1 in voided urine and compared the observed values with those of CYFRA21-1, NMP-22, and voided urine cytology in bladder cancer (BCa). We collected voided urine samples from 154 patients newly diagnosed with BCa, before surgery and from 61 control subjects. Protein levels of COL4A1, COL13A1, CYFRA21-1, and NMP-22 in urine supernatants were measured using enzyme-linked immunosorbent assays. The diagnostic performance and optimal cutoff values were determined by receiver operating characteristic analysis. Urine levels of COL4A1, COL13A1, the combined values of COL4A1 and COL13A1 (COL4A1+COL13A1), and CYFRA21-1 were significantly elevated in urine from patients with BCa compared to the controls. Among these biomarkers, the optimal cutoff value of COL4A1+COL13A1 at 1.33 ng/mL resulted in 57.4

作者:Makito, Miyake;Yosuke, Morizawa;Shunta, Hori;Yoshihiro, Tatsumi;Sayuri, Onishi;Takuya, Owari;Kota, Iida;Kenta, Onishi;Daisuke, Goto;Yasushi, Nakai;Satoshi, Anai;Yoshitomo, Chihara;Kazumasa, Torimoto;Katsuya, Aoki;Nobumichi, Tanaka;Keiji, Shimada;Noboru, Konishi;Kiyohide, Fujimoto

来源:Cancer science 2017 年

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:22
作者:
Makito, Miyake;Yosuke, Morizawa;Shunta, Hori;Yoshihiro, Tatsumi;Sayuri, Onishi;Takuya, Owari;Kota, Iida;Kenta, Onishi;Daisuke, Goto;Yasushi, Nakai;Satoshi, Anai;Yoshitomo, Chihara;Kazumasa, Torimoto;Katsuya, Aoki;Nobumichi, Tanaka;Keiji, Shimada;Noboru, Konishi;Kiyohide, Fujimoto
来源:
Cancer science 2017 年
标签:
Collagen Enzyme-Linked Immunosorbent Assay Recurrence Urinary Bladder Neoplasms Urine
Collagen type 4 alpha 1 (COL4A1) and collagen type 13 alpha 1 (COL13A1) produced by urothelial cancer cells support the vital oncogenic property of tumor invasion. We investigated the diagnostic and prognostic capability of COL4A1 and COL13A1 in voided urine and compared the observed values with those of CYFRA21-1, NMP-22, and voided urine cytology in bladder cancer (BCa). We collected voided urine samples from 154 patients newly diagnosed with BCa, before surgery and from 61 control subjects. Protein levels of COL4A1, COL13A1, CYFRA21-1, and NMP-22 in urine supernatants were measured using enzyme-linked immunosorbent assays. The diagnostic performance and optimal cutoff values were determined by receiver operating characteristic analysis. Urine levels of COL4A1, COL13A1, the combined values of COL4A1 and COL13A1 (COL4A1+COL13A1), and CYFRA21-1 were significantly elevated in urine from patients with BCa compared to the controls. Among these biomarkers, the optimal cutoff value of COL4A1+COL13A1 at 1.33 ng/mL resulted in 57.4